Emergent BioSolutions remains under significant pressure, with persistent revenue, margin, and earnings declines. Learn more ...

In honor of National Naloxone Awareness Day on June 6 th, Emergent BioSolutions Inc. (NYSE: EBS) is teaming up with Victoria’s Voice Foundation – which launched the awareness day with bipartisan ...

Emergent BioSolutions (NYSE:EBS) stock is trading higher on Thursday after the company announced the sale of its facility in Baltimore-Camden to Bora Pharmaceuticals. What Happened: On Thursday prior ...

As Korean food producers navigate rising input costs, margin pressure, and raw material price volatility, biosolutions — ...

Emergent enters into a forbearance agreement, securing flexible credit terms on its existing credit agreement. Emergent BioSolutions sees first-quarter revenue between $200 million and $250 million, ...

Emergent BioSolutions Inc.’s ruination of 15 million doses of COVID-19 vaccine at its Baltimore plant was not as unexpected as the Gaithersburg-based company would have the public believe, an investor ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The stock price of Emergent Biosolutions (NYSE: EBS), a biopharmaceutical company focused on vaccines and antibody therapeutics for infectious diseases, and opioid overdoses, has seen a 17% drop over ...

The European Centre for Disease Prevention and Control raised its risk level for mpox on Friday. The World Health Organization declared a global public health emergency on Wednesday. Emergent ...

Monday - Friday, 6:00 - 7:00 PM ET Emergent BioSolutions, a behind-the-scenes player in the U.S. coronavirus vaccine program, has built capacity to produce vaccines from AstraZeneca and Johnson & ...

Emergent BioSolutions' top line has been nosediving in recent quarters. The company's operations are also unprofitable, and the business is burning through cash. Its flagship product, Narcan, will ...